CD8A and lung carcinoma: Although patients with MC have a lower risk of developing CRC compared with patients with UC and the general population, MC patients have an increased risk for other malignancies, e.g., lung cancer (8, 28), indicating that the protective effect may be local, e.g., through increased activity of CD8+ CTLs due to the colitis.